Atezolizumab (Atezo) Therapy for Locally Advanced/Metastatic Urinary Tract Carcinoma (Mutc) in Patients (Pts) with Poor Performance Status (Ps): Analysis of the Prospective Global Saul Study.
AuthID
P-00S-VCB
P-00S-VCB